Medicalgorithmics Secures Global Software Distribution Contract with Bittium Biosignals Ltd
Medicalgorithmics, a prominent medtech company listed on the Warsaw stock exchange and part of the sWIG80 index, has finalized a software distribution agreement with Bittium Biosignals Ltd (“Bittium”), a subsidiary of Bittium Corporation, a global provider of secure communication solutions, engineering services, and medical technologies, including devices for diagnosing arrhythmias, listed on the NASDAQ Helsinki. This contract is a direct result of the October 2023 memorandum, which focused on software integration and evaluation, demonstrating the efficacy of Medicalgorithmics’ software in conjunction with Bittium’s devices and its potential for significant collaborative growth and value creation.